Seres Therapeutics (MCRB) Return on Equity [ROE] (2015 - 2026)
Seres Therapeutics' Return on Equity [ROE] came in at -159.93% for Q2 2026, down 366.05 percentage points from 206.12% a year earlier and down 25.40 percentage points from the prior quarter.
Powered by 
Analysis
Seres Therapeutics (MCRB) Return on Equity [ROE] (2015 - 2026) Analysis & Trends
For FY2025, Seres Therapeutics' Return on Equity [ROE] was 19.64%.
- Return on Equity [ROE] carries a five-year change of +162.19 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was -351.62% in FY2022 (-309.47 pp) and -42.14% in FY2021 (+100.40 pp).
- The Q2 2026 figure represents the lowest quarterly Return on Equity [ROE] since Q3 2023.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q3 2021 (a gain of 124.78 percentage points), and the weakest in Q3 2023 (a drop of 1453.32 percentage points).
- Business Quant data shows MCRB's Return on Equity [ROE] at -134.53% (Q1 2026), 12.96% (Q4 2025) and 14.07% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | - |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 4.97% |
| 10 | Seres Therapeutics | 20.29 Mn | -118.55 Mn | - | -159.93% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -159.93% |
| Mar 31, 2026 | -134.53% |
| Dec 31, 2025 | 12.96% |
| Sep 30, 2025 | 14.07% |
| Jun 30, 2025 | 206.12% |
| Mar 31, 2025 | 227.09% |
| Dec 31, 2024 | 0.72% |
| Sep 30, 2023 | -1,961.61% |
| Dec 31, 2022 | -466.71% |
| Sep 30, 2022 | -508.29% |
| Jun 30, 2022 | -196.40% |
| Mar 31, 2022 | -80.73% |
| Dec 31, 2021 | -42.01% |
| Sep 30, 2021 | -23.77% |
| Jun 30, 2021 | -107.67% |
| Mar 31, 2021 | -65.89% |
| Dec 31, 2020 | -49.67% |
| Sep 30, 2020 | -148.55% |
| Mar 31, 2018 | -262.84% |
| Dec 31, 2017 | -122.84% |
API Access
Seres Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MCRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "MCRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MCRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();